MARKET

BLCO

BLCO

Bausch + Lomb Corporation
NYSE
16.98
+0.22
+1.31%
After Hours: 16.98 0 0.00% 17:14 08/13 EDT
OPEN
16.72
PREV CLOSE
16.76
HIGH
17.04
LOW
16.60
VOLUME
410.47K
TURNOVER
--
52 WEEK HIGH
18.92
52 WEEK LOW
13.53
MARKET CAP
6.06B
P/E (TTM)
-35.2355
1D
5D
1M
3M
1Y
5Y
1D
Bausch + Lomb (BLCO) Could Be 57% Undervalued As Board Refresh Draws Attention
Simply Wall St · 4m ago
Insider Sheds Nearly 53,000 Shares of Consumer Health Stock, Valued at Almost $900,000
The Motley Fool · 9h ago
Citi Sticks to Its Buy Rating for Bausch + Lomb Corporation (BLCO)
TipRanks · 11h ago
Is Bausch + Lomb’s Raised 2026 Outlook And Board Refresh Altering The Investment Case For BLCO?
Simply Wall St · 1d ago
These stocks have some of Wall Street’s lowest short interest
Seeking Alpha · 2d ago
Weekly Report: what happened at BLCO last week (0803-0807)?
Weekly Report · 3d ago
Bausch + Lomb reports Q2 results
Seeking Alpha · 08/06 17:24
Bausch + Lomb reaffirms FY26 revenue $5.44B-$5.54B, consensus $5.49B
TipRanks · 08/06 11:25
More
About BLCO
Bausch + Lomb Corporation is an eye health company. It operates through three segments: Vision Care, Pharmaceuticals, and Surgical. Vision Care segment includes both a contact lens and a consumer eye care business that consists of contact lens care products, over-the-counter eye drops and eye vitamins. Pharmaceuticals segment consists of generic pharmaceutical products for post-operative treatments and treatments for a number of eye conditions, such as glaucoma, eye inflammation, ocular hypertension, dry eyes and retinal diseases. Surgical segment consists of medical device equipment, consumables, instruments and technologies for the treatment of cataracts, corneal and vitreous and retinal eye conditions, which includes delivery systems, phacoemulsification equipment and other surgical instruments and devices for cataract surgery. Its brands consist of PreserVision, Biotrue, Artelac, Alaway, Mioclear, Ocuvite, ScoutPro, XIIDRA, Vyzulta, Lotemax, Prolensa, Minims, INFUSE, and many more.

Webull offers Bausch + Lomb Corp stock information, including NYSE: BLCO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BLCO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BLCO stock methods without spending real money on the virtual paper trading platform.